Should Treatment of Hepatitis C in HIV-Seropositive and HIV-Seronegative Patients with Hemophilia Include Induction Doses of Interferon?

  • Hanabusa, Hideji

  • Tokyo Ogikubo Hemophilia Center and Department of Hematology, Ogikubo Hospital

Reprints or correspondence: Hideji Hanabusa, Tokyo Ogikubo Hemophilia Center and Dept. of Hematology, Ogikubo Hospital, 3-1-24 Imagawa, Suginami-ku, Tokyo 167-0035, Japan ([email protected]).

Clinical Infectious Diseases 37(3):p 464-465, August 1, 2003. | DOI: 10.1086/376651
Copyright © Copyright Oxford University Press 2003.